What's new

EMEA-003555-PIP01-23

EMEA-003555-PIP01-23

Jun 11, 2025 - 12:25
 0
EMEA-003555-PIP01-23
EMEA-003555-PIP01-23
Read More

Tags:

Previous Article

Novo Nordisk finds Deep Apple ripe for obesity R&D, inking $812M deal to go beyo...

Next Article

EMEA-003554-PIP01-23

Related Posts

EMEA-003215-PIP01-22-M01

EMEA-003215-PIP01-22-M01

Jun 5, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, Efgartigimod alfa, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Eye disorders, PIP number: P/0111/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 11, 2025  0

Highlights - Second EMA / Alliance for Regenerative Med...

Jun 5, 2025  0